Resultados de la búsqueda - Portal de Modelos de Datos Médicos (MDM-Portal)

Filtrar resultados de búsqueda
Seleccionar modelos de datos

Modelos de datos seleccionados

Debe iniciar sesión para seleccionar modelos de datos para descargar o realizar un análisis.

113 Resultados de la búsqueda.

HR-3 therapy documentation AIEOP-BFM ALL 2009 DRKS00003772 NCT01117441 - HR-3 therapy documentation AIEOP-BFM ALL 2009 NCT01117441

- 09/05/2016 - 1 formulario, 4 itemgroups, 29 items, 1 idioma

Itemgroups: Patient Information, Chemotherapy Regimen, PEG-L-ASP/ Erwinase, Identification and Signature

International Collaborative Treatment Protocol For Children And Adolescents With Acute Lymphoblastic Leukemia. Phase 3 Study. Documentation part. Clinical Trial Number: NCT01117441.

DNX-FLA regimen AIEOP-BFM ALL 2009 DRKS00003772 NCT01117441 - DNX-FLA regimen AIEOP-BFM ALL 2009 NCT01117441

- 09/05/2016 - 1 formulario, 3 itemgroups, 19 items, 1 idioma

Itemgroups: Patient Information, Chemotherapy Regimen, Identification and Signature

International Collaborative Treatment Protocol For Children And Adolescents With Acute Lymphoblastic Leukemia. Phase 3 Study. Documentation part. Clinical Trial Number: NCT01117441.

HR-2 therapy documentation AIEOP-BFM ALL 2009 DRKS00003772 NCT01117441 - HR-2 therapy documentation AIEOP-BFM ALL 2009 NCT01117441

- 09/05/2016 - 1 formulario, 4 itemgroups, 39 items, 1 idioma

Itemgroups: Patient Information, Chemotherapy Regimen, PEG-L-ASP/ Erwinase, Identification and Signature

International Collaborative Treatment Protocol For Children And Adolescents With Acute Lymphoblastic Leukemia. Phase 3 Study. Documentation part. Clinical Trial Number: NCT01117441.

HR-1 therapy documentation AIEOP-BFM ALL 2009 DRKS00003772 NCT01117441 - HR-1 therapy documentation AIEOP-BFM ALL 2009 NCT01117441

- 09/05/2016 - 1 formulario, 4 itemgroups, 38 items, 1 idioma

Itemgroups: Patient Information, Chemotherapy Regimen, PEG-L-ASP/ Erwinase, Identification and Signature

International Collaborative Treatment Protocol For Children And Adolescents With Acute Lymphoblastic Leukemia. Phase 3 Study. Documentation part. Clinical Trial Number: NCT01117441.

Eligibility Acute Lymphoblastic Leukemia NCT02451774

- 18/02/2016 - 1 formulario, 2 itemgroups, 18 items, 1 idioma

Itemgroups: Inclusion Criteria, Exclusion Criteria

Pentoxifylline In Pediatric Acute Lymphoblastic Leukemia During Induction; ODM derived from: https://clinicaltrials.gov/show/NCT02451774

Eligibility Acute Lymphoblastic Leukemia NCT02336282

- 18/02/2016 - 1 formulario, 2 itemgroups, 13 items, 1 idioma

Itemgroups: Inclusion Criteria, Exclusion Criteria

Treatment for Executive Dysfunction in Adult Survivors of Childhood Acute Lymphoblastic Leukemia; ODM derived from: https://clinicaltrials.gov/show/NCT02336282

Eligibility Leukemia, Myeloid, Chronic NCT00167167

- 06/02/2016 - 1 formulario, 2 itemgroups, 12 items, 1 idioma

Itemgroups: Inclusion Criteria, Exclusion Criteria

Donor Lymphocyte Infusion (DLI) for Relapsed (Post Transplant) Leukemia; ODM derived from: https://clinicaltrials.gov/show/NCT00167167

Eligibility Leukemia, Myelocytic, Acute NCT00251368

- 06/02/2016 - 1 formulario, 2 itemgroups, 14 items, 1 idioma

Itemgroups: Inclusion Criteria, Exclusion Criteria

Multicenter Study of 9-Aminocamptothecin (9-AC) in Patients With Refractory Leukemia; ODM derived from: https://clinicaltrials.gov/show/NCT00251368

Eligibility Acute Lymphoblastic Leukemia NCT02042690

- 21/12/2015 - 1 formulario, 2 itemgroups, 12 items, 1 idioma

Itemgroups: Inclusion Criteria, Exclusion Criteria

Haplo-identical HSCT Versus Chemotherapy for Adult Acute Lymphoblastic Leukemia Patients; ODM derived from: https://clinicaltrials.gov/show/NCT02042690

Eligibility Acute Lymphoblastic Leukemia NCT02010931

- 21/12/2015 - 1 formulario, 2 itemgroups, 9 items, 1 idioma

Itemgroups: Inclusion Criteria, Exclusion Criteria

Retrospective Analysis of Survival in Adult MRD Positive Acute Lymphoblastic Leukemia Patients; ODM derived from: https://clinicaltrials.gov/show/NCT02010931

Eligibility Acute Lymphoblastic Leukemia NCT01810120

- 21/12/2015 - 1 formulario, 2 itemgroups, 13 items, 1 idioma

Itemgroups: Inclusion Criteria, Exclusion Criteria

Trial to Assess the Efficacy of a TCR Alfa Beta Depleted Graft in Pediatric Affected by ALL or AML and Receiving an HSCT; ODM derived from: https://clinicaltrials.gov/show/NCT01810120

Eligibility Acute Lymphoblastic Leukemia NCT01744223

- 21/12/2015 - 1 formulario, 2 itemgroups, 15 items, 1 idioma

Itemgroups: Inclusion Criteria, Exclusion Criteria

Safety Study of Gene Modified Donor T-cells Following Partially Mismatched Stem Cell Transplant; ODM derived from: https://clinicaltrials.gov/show/NCT01744223

Utilice este formulario para comentarios, preguntas y sugerencias.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.